SynthesisCardiovascular diabetology2021

Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis.

Takayuki Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.